Dr. Stephan Schaller

Dr. Stephan Schaller is the current CEO at esqLABS. Dr. has also previously worked as a Senior Scientist at ONTOX, Open Systems Pharmacology Management Team, OSMOSES, and esqLABS GmbH. From October 2015 to December 2017, they worked as a Senior Scientist at Sanofi where they were in charge of QSP Platform development & Projects and PBPK. Prior to that, they took a sabbatical from July 2015 to September 2015. From February 2010 to June 2015, they worked as a Modeling Expert at Bayer Technology Services where they were in charge of Diabetes, PBPK/PD, Modeling & Simulation, and Project Lead for Clinical Trials. Dr. Stephan Schaller obtained their PhD from RWTH Aachen University in February 2010 and April 2013. Dr. also worked as a Research Engineer at Insilico Biotechnology from June 2009 to February 2010.

Dr. Stephan Schaller has a Doctor of Philosophy (Ph.D.) in Computational Engineering Sciences from RWTH Aachen University, a Master's degree in Biomedical Engineering from University of Canterbury, and a 09/2009 in Systems Theory and Automatic Control from University of Stuttgart.

Some individuals on their team include Georgios Daskalakis - Software Developer, Pavel Balazki - Senior Consultant, and Vanessa Baier - Operations Manager.